The present invention provides HLA-DR (MHC class II) binding peptides derived from the ovarian/breast cancer associated antigens, Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. The immunogenic peptides can be used in cancer vaccines.
申请公布号
WO2009059011(A9)
申请公布日期
2009.12.30
申请号
WO2008US81799
申请日期
2008.10.30
申请人
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH;UNIVERSITY OF WASHINGTON;KNUTSON, KEITH L.;DISIS, MARY, L.;FIKES, JOHN, D.;BEEBE, MELANIE;ISHIOKA, GLENN
发明人
KNUTSON, KEITH L.;DISIS, MARY, L.;FIKES, JOHN, D.;BEEBE, MELANIE;ISHIOKA, GLENN